Maniklal Shee

Maniklal Shee

Auto-generated profile, based on publicly available information

Maniklal Shee

Department of Chemistry Indian Institute of Technology Kharagpur Kharagpur West Bengal India

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
MSManiklal Shee
Maniklal Shee
NSN. D. Pradeep Singh
N. D. Pradeep Singh
The generation of azide radical (N3˙) occurs from its precursors primarily via a single electron transfer (SET) process or homolytic cleavage by chemical methods or advanced photoredox/electrochemical methods. This in situ generated transient open-shell species has unique characteristic features that set its reactivity. In the past, the azide radical was widely used for various studies in radiation chemistry as a 1e− oxidant of biologically important molecules, but now it is being exploited for synthetic applications based on its addition and intermolecular hydrogen atom transfer (HAT) abilities. Due to the significant role of nitrogen-containing molecules in synthesis, drug discovery, biological, and material sciences, the direct addition onto unsaturated bonds for the simultaneous construction of C–N bond with other (C–X) bonds are indeed worth highlighting. Moreover, the ability to generate O- or C-centered radicals by N3˙ via electron transfer (ET) and intermolecular HAT processes is also well documented. The purpose of controlling the reactivity of this short-lived intermediate in organic transformations drives us to survey: (i) the history of azide radical and its structural properties (thermodynamic, spectroscopic, etc.), (ii) chemical reactivities and kinetics, (iii) methods to produce N3˙ from various precursors, (iv) several significant azide radical-mediated transformations in the field of functionalization with unsaturated bonds, C–H functionalization via HAT, tandem, and multicomponent reaction with a critical analysis of underlying mechanistic approaches and outcomes, (v) concept of taming the reactivity of azide radicals for potential opportunities, in this review.



1 July 2026 in MedComm – Oncology
Verified
Journal Article
Open access
DKDeepak K
Deepak K
PRPritam Kumar Roy
Pritam Kumar Roy
MSManiklal Shee
Maniklal Shee
BMBudhaditya Mukherjee
Budhaditya Mukherjee
AGAoife Ward Gahlawat
Aoife Ward Gahlawat
MMMahitosh Mandal
Mahitosh Mandal
Ferroptosis is a redox‐governed, non‐apoptotic cell death program driven by iron‐dependent lipid peroxidation. Its execution depends on the balance between reactive oxygen species (ROS) generation and hierarchical antioxidant defenses. Despite extensive biochemical mapping, an integrated framework delineating how diverse redox defense systems converge to dictate ferroptotic sensitivity across tumor contexts remains lacking. This review delineates the hallmarks and molecular mechanisms of ferroptosis, examining how ROS sources within mitochondrial, the endoplasmic reticulum, membranes, and the cytoplasm drive lipid peroxidation. The antioxidant landscape is systematically classified into three functional tiers: (1) the primary canonical glutathione‐GPX4 axis, (2) secondary non‐canonical and radical‐trapping systems including FSP1‐CoQ10, GCH1‐BH4, peroxiredoxins, and vitamin K, and (3) tertiary metabolic support and detoxification systems encompassing thioredoxin, AKR1C enzymes, SOD‐catalase, and NADPH regeneration. The regulation of these defenses by master signaling hubs including NRF2, AMPK‐mTOR, ATF4, STAT3, Wnt/beta‐catenin, p53, and ncRNAs is evaluated, alongside oncogenic metabolic adaptations creating exploitable vulnerabilities in high‐plasticity states including epithelial to mesenchymal transition, cancer stem cells, hypoxic, matrix‐detached, and chemoresistant cells. Tumor microenvironment crosstalk among cancer‐associated fibroblasts and immune effectors, including CD8 + T cells, natural killer cells, macrophages, and myeloid‐derived suppressor cells, and therapeutic strategies spanning pharmacological and nanomaterial‐based approaches are further examined. Collectively, this synthesis furnishes a mechanistic framework for precision exploitation of ferroptosis across oncological contexts.